{"protocolSection":{"identificationModule":{"nctId":"NCT00697151","orgStudyIdInfo":{"id":"6372"},"secondaryIdInfos":[{"id":"R01NS032525","type":"NIH","link":"https://reporter.nih.gov/quickSearch/R01NS032525"}],"organization":{"fullName":"Columbia University","class":"OTHER"},"briefTitle":"Patent Foramen Ovale in Cryptogenic Stroke Study","officialTitle":"Patent Foramen Ovale in Cryptogenic Stroke Study","acronym":"PICSS"},"statusModule":{"statusVerifiedDate":"2011-09","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"1993-06"},"primaryCompletionDateStruct":{"date":"2000-06","type":"ACTUAL"},"completionDateStruct":{"date":"2000-06","type":"ACTUAL"},"studyFirstSubmitDate":"2008-06-11","studyFirstSubmitQcDate":"2008-06-11","studyFirstPostDateStruct":{"date":"2008-06-13","type":"ESTIMATED"},"lastUpdateSubmitDate":"2011-09-14","lastUpdatePostDateStruct":{"date":"2011-09-15","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"oldNameTitle":"Shunichi Homma,MD - Principal Investigator","oldOrganization":"Columbia University"},"leadSponsor":{"name":"Columbia University","class":"OTHER"},"collaborators":[{"name":"National Institute of Neurological Disorders and Stroke (NINDS)","class":"NIH"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The study sought to assess the rate of recurrent stroke and death in stroke patients with a patent foramen ovale randomized to treatment with warfarin or aspirin. This was a multicenter study conducted at 48 U.S. Institutions."},"conditionsModule":{"conditions":["Ischemic Stroke","Patent Foramen Ovale"],"keywords":["cerebrovascular diseases","ischemic stroke","patent foramen ovale","warfarin","aspirin","transesophageal echocardiography"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":630,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Warfarin","type":"ACTIVE_COMPARATOR","description":"Warfarin (target International Normalized Ratio: 1.4 to 2.8) plus placebo aspirin","interventionNames":["Drug: Warfarin"]},{"label":"Aspirin","type":"ACTIVE_COMPARATOR","description":"Aspirin 325 mg plus placebo warfarin","interventionNames":["Drug: Aspirin"]}],"interventions":[{"type":"DRUG","name":"Warfarin","description":"Warfarin once a day, titrated to obtain an INR of 1.4 to 2.8; placebo aspirin once a day","armGroupLabels":["Warfarin"],"otherNames":["Coumadin"]},{"type":"DRUG","name":"Aspirin","description":"Aspirin 325 mg once a day; placebo warfarin once a day","armGroupLabels":["Aspirin"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Recurrent ischemic stroke and death","timeFrame":"2 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 30-85\n* Ischemic stroke within 30 days\n* Glasgow outcome scale â‰¥ 3\n* No contraindications to warfarin/aspirin\n\nExclusion Criteria:\n\n* Basal INR \\> 1.4\n* Post-procedural stroke\n* Severe carotid atherosclerosis\n* Cardioembolic stroke\n* Contraindications to transesophageal echocardiography","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Shunichi Homma, MD","affiliation":"Columbia University","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Columbia College of Physicians and Surgeons","city":"New York","state":"New York","zip":"10032","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}}]},"referencesModule":{"references":[{"pmid":"12045168","type":"RESULT","citation":"Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP; PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002 Jun 4;105(22):2625-31. doi: 10.1161/01.cir.0000017498.88393.44."},{"pmid":"15232117","type":"RESULT","citation":"Homma S, DiTullio MR, Sacco RL, Sciacca RR, Mohr JP; PICSS Investigators. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Stroke. 2004 Sep;35(9):2145-9. doi: 10.1161/01.STR.0000135773.24116.18. Epub 2004 Jul 1."},{"pmid":"13678932","type":"RESULT","citation":"Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy. J Am Coll Cardiol. 2003 Sep 17;42(6):1066-72. doi: 10.1016/s0735-1097(03)00907-0."},{"pmid":"19380621","type":"DERIVED","citation":"Di Tullio MR, Russo C, Jin Z, Sacco RL, Mohr JP, Homma S; Patent Foramen Ovale in Cryptogenic Stroke Study Investigators. Aortic arch plaques and risk of recurrent stroke and death. Circulation. 2009 May 5;119(17):2376-82. doi: 10.1161/CIRCULATIONAHA.108.811935. Epub 2009 Apr 20."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000054092","term":"Foramen Ovale, Patent"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000006344","term":"Heart Septal Defects, Atrial"},{"id":"D000006343","term":"Heart Septal Defects"},{"id":"D000006330","term":"Heart Defects, Congenital"},{"id":"D000018376","term":"Cardiovascular Abnormalities"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000000013","term":"Congenital Abnormalities"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M27260","name":"Foramen Ovale, Patent","asFound":"Patent Foramen Ovale","relevance":"HIGH"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M9122","name":"Heart Septal Defects, Atrial","relevance":"LOW"},{"id":"M9121","name":"Heart Septal Defects","relevance":"LOW"},{"id":"M9108","name":"Heart Defects, Congenital","relevance":"LOW"},{"id":"M12","name":"Congenital Abnormalities","relevance":"LOW"},{"id":"M20193","name":"Cardiovascular Abnormalities","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"}]},"interventionBrowseModule":{"meshes":[{"id":"D000001241","term":"Aspirin"},{"id":"D000014859","term":"Warfarin"}],"ancestors":[{"id":"D000000894","term":"Anti-Inflammatory Agents, Non-Steroidal"},{"id":"D000018712","term":"Analgesics, Non-Narcotic"},{"id":"D000000700","term":"Analgesics"},{"id":"D000018689","term":"Sensory System Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000000893","term":"Anti-Inflammatory Agents"},{"id":"D000018501","term":"Antirheumatic Agents"},{"id":"D000005343","term":"Fibrinolytic Agents"},{"id":"D000050299","term":"Fibrin Modulating Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000010975","term":"Platelet Aggregation Inhibitors"},{"id":"D000016861","term":"Cyclooxygenase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000058633","term":"Antipyretics"},{"id":"D000000925","term":"Anticoagulants"}],"browseLeaves":[{"id":"M4238","name":"Aspirin","asFound":"Knee","relevance":"HIGH"},{"id":"M17292","name":"Warfarin","asFound":"Third","relevance":"HIGH"},{"id":"M3907","name":"Anti-Inflammatory Agents","relevance":"LOW"},{"id":"M3908","name":"Anti-Inflammatory Agents, Non-Steroidal","relevance":"LOW"},{"id":"M3722","name":"Analgesics","relevance":"LOW"},{"id":"M20476","name":"Analgesics, Non-Narcotic","relevance":"LOW"},{"id":"M20294","name":"Antirheumatic Agents","relevance":"LOW"},{"id":"M8163","name":"Fibrinolytic Agents","relevance":"LOW"},{"id":"M13555","name":"Platelet Aggregation Inhibitors","relevance":"LOW"},{"id":"M18899","name":"Cyclooxygenase Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"M28866","name":"Antipyretics","relevance":"LOW"},{"id":"M3934","name":"Anticoagulants","relevance":"LOW"}],"browseBranches":[{"abbrev":"Antipy","name":"Antipyretics"},{"abbrev":"Infl","name":"Anti-Inflammatory Agents"},{"abbrev":"ARhu","name":"Antirheumatic Agents"},{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"Analg","name":"Analgesics"},{"abbrev":"PlAggInh","name":"Platelet Aggregation Inhibitors"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"AnCoag","name":"Anticoagulants"}]}},"hasResults":false}